Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08SJL
|
|||
Former ID |
DNC005833
|
|||
Drug Name |
4-Ethynyl-2-(4-hydroxy-phenyl)-quinolin-6-ol
|
|||
Synonyms |
4-ethynyl-2-(4-hydroxyphenyl)quinolin-6-ol
Click to Show/Hide
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
![]() |
Download2D MOL |
||
Formula |
C17H11NO2
|
|||
Canonical SMILES |
C#CC1=CC(=NC2=C1C=C(C=C2)O)C3=CC=C(C=C3)O
|
|||
InChI |
1S/C17H11NO2/c1-2-11-9-17(12-3-5-13(19)6-4-12)18-16-8-7-14(20)10-15(11)16/h1,3-10,19-20H
|
|||
InChIKey |
LZRCWCHYOCKNED-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ERbeta ligands. Part 4: Synthesis and structure-activity relationships of a series of 2-phenylquinoline derivatives. Bioorg Med Chem Lett. 2005 Oct 15;15(20):4520-5. | |||
REF 2 | ERbeta ligands. Part 6: 6H-Chromeno[4,3-b]quinolines as a new series of estrogen receptor beta-selective ligands. Bioorg Med Chem Lett. 2007 Jul 15;17(14):4053-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.